A peer-reviewed study has validated the analytical performance of ImmunoPrism, a novel RNA-based immune profiling assay from Cofactor Genomics. buff.ly/2Z53BTQ

Join Cofactor's CEO, Jarret Glasscock, on September 23 for a Panel Discussion featuring immuno-oncology experts hosted by Oncology Central. Register here: event.on24.com/eventRegistrat…

Read the latest from MedCity News on why is RNA is a better measure of a patient’s current health than DNA. Learn how we measure the dynamic immune response and capture a more comprehensive picture of what’s happening at the site of the solid tumor: ow.ly/a8Wn50Bnzap

We're proud to announce a collaboration that has the potential to make an impact for #oncology patients! UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck Cancer Read the full release: cofactorgenomics.reportablenews.com/pr/ucsd-partne… #precisionmedicine #RNA

Cofactor Genomics Bridges the Precision Medicine Gap Using AWS and Machine Learning - watch the Amazon Web Services Case Study featuring Cofactor Genomics: ow.ly/Xe9g50BUGs7 #RNA #precisionmedicine #multidimensionalbiomarkers #oncologyresearch

Matching patients to therapies is an integral part of closing the precision medicine gap. Why does this remain a challenge? Learn more: biotechniques.com/cancer-researc… #RNA #precisionmedicine #oncology #FutureofDx

Why the Precision Medicine Gap is the Biggest Threat to Healthcare and Why Predictive Diagnostics is the Key to Achieving True Precision Medicine - read the full article at DiagnosticsWorld: ow.ly/AQ0g50BUGAf #RNA #precisionmedicine #healthcare

Are you Team RNA or Team DNA? Read our take in Biomarkers and a Battle of the Bases! pharmatimes.com/magazine/2020/…. #RNA #DNA #biomarkers

Interested in what it's like to work for Cofactor in one of our business roles? Hear the experiences of our VP of Market Development in a recent ChemVoices Webinar: chemvoices.org/chemists-beyon… and find more info on our careers page: cofactorgenomics.com/careers/

Did you read last week's post on the Battle of the Bases? Here, we take it one step further and discuss, "Why RNA is a better measure of a patient’s current health than DNA" medcitynews.com/2020/09/why-rn… #RNA #DNA #biomarkers #healthcare #diagnostics

Predictive diagnostics are an essential part of #oncology #precisionmedicine Read an interview with Douglas Adkins featured in Oncology Central discussing the precision medicine field, it’s challenges, and novel predictive technology in oncology. ow.ly/vDXY50CgCXB

Cofactor has been recognized as one of the 5 Best HealthTech Solutions Providers to Watch in 2020! Read the interview with our CEO, Jarret Glasscock, in honor of this recognition: thesiliconreview.com/magazine/profi… #RNA #futureofdx #precisionmedicine #predictivemedicine

Scientific and medical research is an investment in our future, but it's not a short term investment. Learn why we believe the future of diagnostics requires a new approach to trials, in the December issue of Clinical Researcher: ow.ly/g3WI50CNE0M #precisionmedicine #RNA

New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer - Read the Press Release summarizing the results and methods: ow.ly/9kTR50DSYiK #RNA #futureofDx #precisionmedicine

Check out this awesome interview in ConvergenceRI, featuring our collaborator, Dr. Jennifer Ribeiro, whose research study on ovarian cancer was recently published! Learn how our technology is building a better clinical approach to treating ovarian cancer: ow.ly/dhrJ50DTy4X

How did you celebrate #IWD2021? Natalie LaFranzo shared more about her role at Cofactor and what led her to #science in a panel for students and teachers, hosted by the American Chemical Society : acs.org/content/acs/en… #womeninscience #womeninstem

New Data Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer Jennifer Ribeiro, PhD Brown University Women & Infants Cofactor Genomics #OvarianCancer #Cancer #Research oncologytube.com/video/39839/je…

How do we navigate #precisionmedicine? Read about Multidimensional Predictive Diagnostics: The GPS of Clinical Practice in the latest issue of the Journal of Precision Medicine: ow.ly/2TIz50EhKIj #RNA #futureofdx #oncology

Today, we announced our first multicenter clinical trial. Fifteen sites, including Mayo Clinic, MultiCare Institute for Research and Innovation, and Revive Research Institute, are currently enrolling for the PREDAPT Trial: ow.ly/BYHj50EhLKD